Capstone Therapeutics Corp. (CAPS) vs Cementos Pacasmayo S.A.A. (CPAC)
Capstone Therapeutics Corp. and Cementos Pacasmayo S.A.A. are both Building Materials companies. Cementos Pacasmayo S.A.A. is the larger, with a market value of $1.0B against $3.7M — 279.1× the size. Capstone Therapeutics Corp. has negative trailing earnings, so its P/E is not meaningful; Cementos Pacasmayo S.A.A. trades at 17.0×. Capstone Therapeutics Corp. grew revenue faster over the last twelve months: 38.9% against 19.8%. Cementos Pacasmayo S.A.A. has the higher net margin (9.59% vs −36.7%) and the higher return on invested capital (10.9% vs −17.2%). Across the 18 metrics below, Cementos Pacasmayo S.A.A. leads on 12 and Capstone Therapeutics Corp. on 6.
Valuation
Profitability
| Metric | CAPS | CPAC | Building Materials median |
|---|---|---|---|
| Gross margin | 25.40% | 39.99% | 27.27% |
| Operating margin | (17.20%) | 19.54% | 13.85% |
| Net margin | (36.68%) | 9.59% | 9.59% |
| Free cash flow margin | (6.33%) | 16.71% | 8.06% |
| Return on equity | (114.39%) | 16.65% | 9.62% |
| Return on assets | (41.47%) | 6.90% | 5.86% |
| Return on invested capital | (17.20%) | 10.86% | 6.03% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack